[1]王 畅,祝清国.肾移植术后尿路上皮癌发病特点的文献统计分析[J].医学信息,2018,31(13):123-126,130.[doi:10.3969/j.issn.1006-1959.2018.13.036]
　WANG Chang,ZHU Qing-guo.Literature and Statistical Analysis of the Characteristics of Urothelial Carcinoma after Renal Transplantation[J].Journal of Medical Information,2018,31(13):123-126,130.[doi:10.3969/j.issn.1006-1959.2018.13.036]
点击复制

肾移植术后尿路上皮癌发病特点的文献统计分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年13期
页码:
123-126,130
栏目:
调查分析
出版日期:
2018-07-01

文章信息/Info

Title:
Literature and Statistical Analysis of the Characteristics of Urothelial Carcinoma after Renal Transplantation
文章编号:
1006-1959（2018）13-0123-05
作者:
王 畅; 祝清国
哈尔滨医科大学附属第二医院泌尿外科一病房，黑龙江 哈尔滨 150006
Author(s):
WANG Chang; ZHU Qing-guo
Department of Urology,Ward One,the Second Affiliated Hospital of Harbin Medical University,Harbin 150006,Heilongjiang,China
关键词:
肾移植; 尿路上皮癌; 文献统计分析
Keywords:
Key words：Renal transplantation; Urothelial carcinoma; Literature and statistical analysis
分类号:
R737.1
DOI:
10.3969/j.issn.1006-1959.2018.13.036
文献标志码:
A
摘要:
目的 统计分析国内肾移植尿路上皮癌患者的发病率、发病特点，提高临床工作中对此类疾病的认识。方法 检索目前从2005~2017年的国内权威中文数据库中国知网全文数据库和万方全文数据库，分别按照发病率、发病年龄、性别、发病部位、发病时间、马兜铃酸肾病的影响等方面收集统计数据，分析其临床意义。结果 文献统计肾移植术后尿路上皮癌的发病率约1.17~2.27%，高于普通人群中的发病率；发病年龄45~56岁；女性发病率64.93%，高于男性35.07%，差异有统计学意义（P＜0.05）；原上尿路发病率50.81%，高于膀胱49.19%，，移植肾同侧发病率70.80%，高于对侧为29.20%，差异无统计学意义（P＞0.05）；发病时间的分布主要在肾移植术后1~16.8个月内；相应文献报道马兜铃酸肾病是肾移植术后尿路上皮癌发病和复发的危险因素。结论 具有马兜铃酸肾病病史的女性患者是肾移植术后尿路上皮癌发生的高危人群，对高危患者的诊断和治疗应该更加重视，改进治疗方案，做到早发现早治疗。
Abstract:
Abstract：Objective To analyze the incidence and characteristics of urothelial carcinoma in patients with renal transplantation and to improve the understanding of such diseases in clinical work.Methods This paper retrieves the full text database of Chinese knowledge network and the full text database of Chinese authoritative Chinese database from 2005~2017,and collect statistical data according to the incidence,age,sex,location,time of onset,the influence of aristolochic acid nephropathy and so on,and analyze its clinical significance.Results The incidence of urothelial carcinoma after renal transplantation is about 1.17~2.27%,which is higher than that in the general population;the age of onset is 45~56 years old;the incidence rate of female is 64.93%,which is higher than that of male 35.07%,the difference was statistically significant(P<0.05);the incidence of the original upper urinary tract was 50.81%, which was higher than that of the bladder 49.19%,and the incidence rate of ipsilateral transplantation was 70.80%,which was higher than that of the contralateral side 29.20%,the difference was not statistically significant(P>0.05);the distribution of onset time was mainly within 1~16.8 months after renal transplantation;the corresponding literature reported that aristolochic acid nephropathy is a risk factor for the onset and recurrence of urothelial carcinoma after renal transplantation.Conclusion Female patients with a history of aristolochic acid nephropathy are at high risk of urothelial carcinoma after renal transplantation.The diagnosis and treatment of high-risk patients should be paid more attention to,and the treatment plan should be improved to achieve early detection and early treatment.

参考文献/References:

[1]田野.中国肾移植术后新发恶性肿瘤总结分析[C]//中华医学会、中华医学会器官移植学分会、中华医学会外科学分会器官移植学组、中国工程院医药卫生学部.2013中国器官移植大会论文汇编.中华医学会、中华医学会器官移植学分会、中华医学会外科学分会器官移植学组、中国工程院医药卫生学部:,2013:1. [2]杨宏伟,刘龙.马兜铃酸肾病肾移植术后并发泌尿系肿瘤5例并文献复习[J].现代泌尿生殖肿瘤杂志,2011,3(01):45. [3]周颖,黄丽华,梁雁等.服含马兜铃酸中药患者肾移植术后发生继发肿瘤风险的调查[J].药物不良反应杂志,2009,11(01):9-12. [4]肖龙仁,杨亦荣,夏鹏,.马兜铃酸肾病肾移植术后泌尿系统并发尿路上皮癌8例临床分析[J].解放军医学杂志,2010,35(04):442-444. [5]王芳,肖漓,孟祥红.我院2013-2015年肾移植患者术后感染的流行病学研究[J].解放军医药杂志,2016,28(04):75-77. [6]Tian J,Niu L,An X.Cardiovascular risks in chronic kidney disease pediatric patients[J].Experimental&Therapeutic Medicine, 2017,14(5):4615-4619. [7]陈花,王振兴,周华.肾移植术后并发自体泌尿系统恶性肿瘤25例临床分析[J].中国药物与临床,2015,15(3):404-406. [8]温晖. DNA修复基因和毒物代谢基因单核苷酸多态与膀胱癌遗传易感性[D].复旦大学,2009. [9]梁爱华,高月,张伯礼.含马兜铃酸中药的安全性问题及对策[J].中国食品药品监管,2017(11):17-20. [10]施珍,金领微,高依依.血液透析患者获得性肾囊肿的临床回顾分析[J].中国中西医结合肾病杂志,2014,15(01):46-47. [11]贾保祥,林俊,武俊杰.肾移植供受体HLA错配与术后并发恶性肿瘤的关系[J].器官移植,2014,5(04):227-230. [12]方祺.HLA-G、IL-10在肾移植术后尿路上皮癌中的表达及相关性研究[D].天津医科大学,2013. [13]Suthanthiran M,Hojo M,Maluccio M,et al.Post-transplantation malignancy:a cell autonomous mechanism with implications for therapy[J].Transactions of the American Clinical&Climatological Association,2009,120(3):369. [14]Liu S,Chaudhry M R,Berrebi A A,et al.Polyomavirus Replication and Smoking Are Independent Risk Factors for Bladder Cancer After Renal Transplantation[J].Transplantation,2016,101(6):1488. [15]王超,李涛,张健,等.中国肾移植术后并发恶性肿瘤趋势分析[J]. 器官移植, 2015(3):169-173. [16]胡小朋,马麟麟,张小东.肾移植术后并发尿路上皮肿瘤的临床分析[J].中华泌尿外科杂志,2006,27(7):493-495. [17]郝晓军.肾移植术后并发自体尿路上皮恶性肿瘤26例的临床分析[J].山西职工医学院学报,2016,26(06):4-6. [18]韩苏军,张思维,陈万青,等.中国膀胱癌发病现状及流行趋势分析[J].癌症进展,2013,11(1):89-95. [19]刘余庆,卢剑,赵磊.肾移植受者上尿路尿路上皮癌术后膀胱复发的预后因素[J].北京大学学报（医学版）,2015,47(4):605-610. [20]田野,侯海军,郭宇文.肾移植患者单侧上尿路上皮肿瘤术后对侧尿路预防性切除的必要性[J].北京大学学报(医学版),2013,45(04):558-561. [21]谷建营,张维颉,顾润国.肾移植术后并发实体肿瘤的临床分析[J].山东医学高等专科学校学报,2017,39(02):113-118.

相似文献/References:

[1]李 茂,康 简,梁思敏.颅内出血心脑死亡器官捐献供体的安全性评估[J].医学信息,2018,31(07):53.[doi:10.3969/j.issn.1006-1959.2018.07.018]
　LI Mao,KANG Jian,LIANG Si-min.Evaluation of the Safety of Intracranial Hemorrhage Donors for Organ Donation[J].Journal of Medical Information,2018,31(13):53.[doi:10.3969/j.issn.1006-1959.2018.07.018]
[2]王俊全,祝清国.肾移植术后感染性腹泻的诊疗分析[J].医学信息,2019,32(02):51.[doi:10.3969/j.issn.1006-1959.2019.02.017]
　WANG Jun-quan,ZHU Qing-guo.Diagnosis and Treatment of Infectious Diarrhea after Renal Transplantation[J].Journal of Medical Information,2019,32(13):51.[doi:10.3969/j.issn.1006-1959.2019.02.017]
[3]张建强,蒋 鹏,顾新伟,等.公民逝世后器官捐献合并AKI供体肾移植的疗效观察[J].医学信息,2019,32(12):96.[doi:10.3969/j.issn.1006-1959.2019.12.029]
　ZHANG Jian-qiang,JIANG Peng,GU Xin-wei,et al.Therapeutic Effect of Organ Donation Combined with AKI Donor Kidney Transplantation after the Death of Citizens[J].Journal of Medical Information,2019,32(13):96.[doi:10.3969/j.issn.1006-1959.2019.12.029]
[4]郑冰冰,祝清国.BK病毒感染与肾移植研究[J].医学信息,2020,33(05):49.[doi:10.3969/j.issn.1006-1959.2020.05.015]
　ZHENG Bing-bing,ZHU Qing-guo.Research on BK Virus Infection and Kidney Transplantation[J].Journal of Medical Information,2020,33(13):49.[doi:10.3969/j.issn.1006-1959.2020.05.015]
[5]董 梅,顾云娜,李兴勤,等.蛋白A免疫吸附清除致敏肾移植受者HLA抗体的临床观察[J].医学信息,2023,36(06):101.[doi:10.3969/j.issn.1006-1959.2023.06.022]
　DONG Mei,GU Yun-na,LI Xing-qin,et al.Clinical Observation of the Clearance of HLA Antibodies in Sensitized Renal Transplant Recipients by Protein A Immunoadsorption[J].Journal of Medical Information,2023,36(13):101.[doi:10.3969/j.issn.1006-1959.2023.06.022]

更新日期/Last Update: 2018-07-01